Table 2.
Criteria | Australia 2010 [1] |
UK 2011 [2] |
Canada 2012 [3, 4] |
New Zealand 2017a [42] | Canada 2017a [10] |
---|---|---|---|---|---|
Published in last 5y | N | N | Y | Y | Y |
Followed GRADE process | N | N | Y | N | Y |
Addressed clear questions (can identify PICO elements) | ? | N | Y | ? | Y |
Had benefits and harms assessments | ? | ? | Y | ? | Y |
Assessed using AGREE | N | N | Y | N | Y |
Allowed for updating | ? | N | Y | ? | Y |
Had existing and accessible evidence tables/summaries | ? | N | Y | N | Y |
Had risk of bias assessment | N | N | Y | N | Y |
Were integrated (24 h) | N | N | N | Y | Y |
Reference: Appendix 1. GRADE-ADOLOPMENT [11]
Y yes, N no, ? unsure
aunder development during guideline development process but made available to Australian Consensus Panel